Ramm Pharma Corp Stock Net Income
Fundamental analysis of RAMM Pharma allows traders to better anticipate movements in RAMM Pharma's stock price by examining its financial health and performance throughout various phases of its business cycle.
RAMM |
RAMM Pharma Corp Company Net Income Analysis
RAMM Pharma's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current RAMM Pharma Net Income | (7.11 M) |
Most of RAMM Pharma's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RAMM Pharma Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, RAMM Pharma Corp reported net income of (7.11 Million). This is 102.08% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is 101.24% higher than that of the company.
RAMM Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RAMM Pharma's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of RAMM Pharma could also be used in its relative valuation, which is a method of valuing RAMM Pharma by comparing valuation metrics of similar companies.RAMM Pharma is currently under evaluation in net income category among its peers.
RAMM Fundamentals
| Return On Equity | -0.12 | |||
| Return On Asset | -0.0789 | |||
| Profit Margin | (1.76) % | |||
| Operating Margin | (1.89) % | |||
| Current Valuation | 1.85 M | |||
| Shares Outstanding | 122.4 M | |||
| Shares Owned By Insiders | 34.88 % | |||
| Shares Owned By Institutions | 0.89 % | |||
| Price To Book | 0.18 X | |||
| Price To Sales | 4.04 X | |||
| Revenue | 4.12 M | |||
| Gross Profit | (37.32 K) | |||
| EBITDA | (6.36 M) | |||
| Net Income | (7.11 M) | |||
| Cash And Equivalents | 12.79 M | |||
| Cash Per Share | 0.10 X | |||
| Total Debt | 8.69 K | |||
| Current Ratio | 9.18 X | |||
| Book Value Per Share | 0.41 X | |||
| Cash Flow From Operations | (3.82 M) | |||
| Earnings Per Share | (0.05) X | |||
| Beta | -0.75 | |||
| Market Capitalization | 15.16 M | |||
| Total Asset | 59.71 M | |||
| Net Asset | 59.71 M |
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Consideration for investing in RAMM Pink Sheet
If you are still planning to invest in RAMM Pharma Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RAMM Pharma's history and understand the potential risks before investing.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |